NCT06187467

Brief Summary

Balance and gait recovery is a critical aspect of post-stroke motor rehabilitation. Researchers have effectively utilized EEG to investigate different aspects of lower limb motor control, however there are several technical challenges in the existing brain computer interface (BCI) motor profiling. The study aims to test the EEG-BCI system to see if it's effective in understanding the balance and walking patterns of post-stroke populations.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jul 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 4, 2023

Completed
29 days until next milestone

First Posted

Study publicly available on registry

January 2, 2024

Completed
6 months until next milestone

Study Start

First participant enrolled

July 1, 2024

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2025

Completed
Last Updated

April 11, 2025

Status Verified

April 1, 2025

Enrollment Period

1.3 years

First QC Date

December 4, 2023

Last Update Submit

April 8, 2025

Conditions

Keywords

Electroencephalographic (EEG)Brain Computer Interfaces

Outcome Measures

Primary Outcomes (2)

  • EEG Activities

    To record EEG and EOG data from 64-Ch ActiCap EEG cap and electrode

    Week 0 (baseline), 4 (1st follow-up assessment), 8 (last follow-up assessment)

  • Goniometers

    7 sensors to measure 2-axis joint angles at bilateral Hip, Knee and Ankle

    Week 0 (baseline), 4 (1st follow-up assessment), 8 (last follow-up assessment)

Secondary Outcomes (5)

  • Fugl Meyer Assessment for Lower Limbs

    Week 0 (baseline), 4 (1st follow-up assessment), 8 (last follow-up assessment)

  • Berg Balance Scale

    Week 0 (baseline), 4 (1st follow-up assessment), 8 (last follow-up assessment)

  • Modified Clinical Test for Sensory Interaction in Balance

    Week 0 (baseline), 4 (1st follow-up assessment), 8 (last follow-up assessment)

  • 10-metre Walk Test

    Week 0 (baseline), 4 (1st follow-up assessment), 8 (last follow-up assessment)

  • 6-minute Walk Test

    Week 0 (baseline), 4 (1st follow-up assessment), 8 (last follow-up assessment)

Interventions

Assessments and questionnaires to quantify cortical and motor activities using portable EEG and lower limb sensors during dynamic balance and gait activities.

Eligibility Criteria

Age21 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients in outpatient clinics

You may qualify if:

  • First-ever clinical stroke (ischaemic or haemorrhagic) confirmed by admitting doctors brain imaging
  • Age 21 to 85 years
  • At least ≥ 30 days post-stroke
  • Gait impairments related to stroke
  • Functional ambulation category -6 levels (Mehrholz et al, 2007): FAC ≥ 4, i.e. able to ambulate independently on level surface but requires supervision to negotiate (e.g. stairs, inclines, non-level surfaces).
  • Montreal Cognitive Assessment (MoCA) score \> 21 (Nasreddine et al., 2005)
  • Able to understand study instructions and requirements

You may not qualify if:

  • Non-stroke related causes of gait impairment
  • Medical conditions incompatible with research participation: uncontrolled medical illnesses (hypertension or diabetes, ischaemic heart disease, congestive heart failure, bronchial asthma, severe /untreated depression, agitation, end stage renal/liver/heart/lung failure, dialysis, unresolved cancers e.g.,), active seizures within 3 months
  • Anticipated life expectancy of \< 6 months
  • On subcutaneous or oral anti-coagulation
  • Local factors potentially worsened by gait training: joint and muscle pains
  • Lower limb pain VAS \>4/10, active lower limb fractures or arthritis, fixed leg contractures, severe peripheral vascular disease, organomegaly or aortic aneurysms
  • Active unhealed skin wounds or inflammatory skin conditions over trunk and lower limbs,
  • Severe visual impairment or visual neglect affecting navigation
  • Known allergy to EEG gel (Recoverix)
  • Presence of craniectomy skull defect
  • Resident of nursing home or overseas country which may compromise attendance at research site
  • Pregnant or lactating females

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tan Tock Seng Hospital

Singapore, Singapore, Singapore

RECRUITING

MeSH Terms

Conditions

Stroke

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Dr Wee Seng Kwee

    Tan Tock Seng Hospital

    PRINCIPAL INVESTIGATOR
  • Dr Karen Chua

    Tan Tock Seng Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Low Ai Mei Jaclyn

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 4, 2023

First Posted

January 2, 2024

Study Start

July 1, 2024

Primary Completion

October 1, 2025

Study Completion

October 1, 2025

Last Updated

April 11, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations